Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Dynegy Inc
DYN | US
18.90
USD-0.77
-3.91%
DYN | US
About Dynegy Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
23/04/2026
Close
18.90
Open
19.41
High
19.47
Low
18.29
Dyne Therapeutics Inc. a muscle disease company operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1 duchenne muscular dystrophy and facioscapulohumeral dystrophy as well as rare skeletal muscle and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics Inc. was incorporated in 2017 and is headquartered in Waltham Massachusetts.
View LessDYN | US
Risk
57.3
Sharpe
1.00
Luna's Score
48/100
Recommendation
Hold
Luna says (DYN | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
52.4%1 month
57.3%3 months
70.7%6 months
93.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.56
Debt to equity
0.03
Debt to assets
0.03
Ent. to EBITDA
-8.87
Ent. to rev.
-
PEG
0.19
Other Fundamentals
EBITDA
-269.47M
MarketCap
1.90B
MarketCap(USD)
1.90B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-52.46
Short ratio
4.43
Short perc.
10.53
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
3.29
Range1M
4.56
Range3M
7.43
Volumes: Market Activity
Rel. volume
0.98
Price X volume
33.80M
